Incidental Mutation 'R6284:Braf'
ID 508106
Institutional Source Beutler Lab
Gene Symbol Braf
Ensembl Gene ENSMUSG00000002413
Gene Name Braf transforming gene
Synonyms D6Ertd631e, 9930012E13Rik, Braf2, Braf-2
MMRRC Submission 044454-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R6284 (G1)
Quality Score 225.009
Status Validated
Chromosome 6
Chromosomal Location 39580171-39702397 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 39665216 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Phenylalanine to Leucine at position 51 (F51L)
Ref Sequence ENSEMBL: ENSMUSP00000099036 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000002487] [ENSMUST00000101497]
AlphaFold P28028
Predicted Effect probably benign
Transcript: ENSMUST00000002487
AA Change: F85L

PolyPhen 2 Score 0.097 (Sensitivity: 0.93; Specificity: 0.85)
SMART Domains Protein: ENSMUSP00000002487
Gene: ENSMUSG00000002413
AA Change: F85L

DomainStartEndE-ValueType
low complexity region 5 30 N/A INTRINSIC
low complexity region 46 56 N/A INTRINSIC
coiled coil region 94 121 N/A INTRINSIC
RBD 139 211 1.04e-33 SMART
C1 219 264 1.05e-13 SMART
low complexity region 297 311 N/A INTRINSIC
low complexity region 316 326 N/A INTRINSIC
low complexity region 459 474 N/A INTRINSIC
Pfam:Pkinase_Tyr 494 751 9.6e-65 PFAM
Pfam:Pkinase 494 753 5.1e-60 PFAM
Pfam:Kinase-like 573 741 3e-11 PFAM
Predicted Effect possibly damaging
Transcript: ENSMUST00000101497
AA Change: F51L

PolyPhen 2 Score 0.730 (Sensitivity: 0.86; Specificity: 0.92)
SMART Domains Protein: ENSMUSP00000099036
Gene: ENSMUSG00000002413
AA Change: F51L

DomainStartEndE-ValueType
low complexity region 12 22 N/A INTRINSIC
coiled coil region 60 88 N/A INTRINSIC
low complexity region 93 120 N/A INTRINSIC
RBD 138 210 1.04e-33 SMART
C1 218 263 1.05e-13 SMART
low complexity region 296 310 N/A INTRINSIC
low complexity region 315 325 N/A INTRINSIC
low complexity region 406 421 N/A INTRINSIC
Pfam:Pkinase 441 698 8.2e-62 PFAM
Pfam:Pkinase_Tyr 441 698 1.5e-65 PFAM
Pfam:Kinase-like 523 688 3.2e-11 PFAM
Meta Mutation Damage Score 0.1299 question?
Coding Region Coverage
  • 1x: 99.9%
  • 3x: 99.6%
  • 10x: 98.3%
  • 20x: 95.2%
Validation Efficiency 100% (64/64)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene are associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. Mutations in this gene have also been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung. A pseudogene, which is located on chromosome X, has been identified for this gene. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous null embryos die during organogenesis, are smaller, have enlarged blood vessels, hemorrhaging, poor circulation, slow heartbeat and abnormal endothelial cell development. Mice homozygous for a targeted allele activated in neurons exhibit impaired neuronal differentiation. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 62 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
0610030E20Rik G T 6: 72,324,437 (GRCm39) G16C probably damaging Het
Abca7 G A 10: 79,840,244 (GRCm39) V801I probably benign Het
Adgrl2 A T 3: 148,532,143 (GRCm39) L1030Q probably damaging Het
Akap1 T C 11: 88,735,394 (GRCm39) T423A possibly damaging Het
Anpep T A 7: 79,475,550 (GRCm39) D111V probably damaging Het
Atm T A 9: 53,356,676 (GRCm39) probably null Het
Atp5f1a T A 18: 77,866,168 (GRCm39) S106T probably benign Het
Atp5me T C 5: 108,581,925 (GRCm39) I20V probably benign Het
Atp6v0d2 T A 4: 19,922,605 (GRCm39) probably null Het
Bclaf1 T G 10: 20,197,906 (GRCm39) probably null Het
Bod1l A G 5: 41,976,130 (GRCm39) V1728A probably benign Het
Camsap2 A G 1: 136,232,175 (GRCm39) I140T possibly damaging Het
Ccdc24 A T 4: 117,726,850 (GRCm39) probably null Het
Cdh26 G C 2: 178,091,677 (GRCm39) G79R probably damaging Het
Cenpf A G 1: 189,384,939 (GRCm39) L2447P probably damaging Het
Cfap74 T C 4: 155,536,253 (GRCm39) F863L probably damaging Het
Clstn2 C T 9: 97,336,727 (GRCm39) G917S probably benign Het
Col6a6 A T 9: 105,604,426 (GRCm39) probably null Het
Cul5 G A 9: 53,535,035 (GRCm39) P596L probably damaging Het
Dst A T 1: 34,268,166 (GRCm39) R2863W probably damaging Het
Dthd1 A G 5: 62,971,384 (GRCm39) E69G possibly damaging Het
Elp1 A T 4: 56,762,281 (GRCm39) I1106K probably damaging Het
Erich2 T A 2: 70,370,028 (GRCm39) I402N probably damaging Het
Fam162b T C 10: 51,461,598 (GRCm39) K155R probably damaging Het
Fhip1a G A 3: 85,579,995 (GRCm39) P737S probably benign Het
Glb1l2 A T 9: 26,678,744 (GRCm39) S466T probably benign Het
Kazn G A 4: 141,844,508 (GRCm39) L402F probably benign Het
Kcnj13 A T 1: 87,314,608 (GRCm39) S205T probably damaging Het
Lama1 T A 17: 68,117,091 (GRCm39) V2462E probably damaging Het
Lce1b A C 3: 92,563,411 (GRCm39) C41G unknown Het
Lyar T A 5: 38,383,339 (GRCm39) W77R probably damaging Het
Marchf11 G A 15: 26,409,432 (GRCm39) R377Q probably benign Het
Mis18bp1 A G 12: 65,185,561 (GRCm39) F869L probably benign Het
Myom1 T A 17: 71,329,887 (GRCm39) Y6* probably null Het
Myzap T C 9: 71,466,207 (GRCm39) I150V probably benign Het
Nop14 C T 5: 34,798,835 (GRCm39) probably null Het
Oprl1 T A 2: 181,359,784 (GRCm39) probably benign Het
Pacsin1 T C 17: 27,927,478 (GRCm39) L432P probably damaging Het
Peak1 A G 9: 56,167,580 (GRCm39) L116P probably benign Het
Plcb2 C T 2: 118,547,782 (GRCm39) V482M probably benign Het
Pnliprp1 T A 19: 58,723,416 (GRCm39) I269N probably damaging Het
Pnpla7 C A 2: 24,906,630 (GRCm39) D664E possibly damaging Het
Ppa2 G A 3: 133,076,178 (GRCm39) R269H probably benign Het
Rps6kb2 G T 19: 4,211,186 (GRCm39) T113K probably benign Het
Rrp7a A T 15: 83,006,061 (GRCm39) I63N probably damaging Het
Slc29a1 A G 17: 45,900,847 (GRCm39) probably null Het
Slco1a7 T C 6: 141,671,119 (GRCm39) D451G probably damaging Het
Stxbp5 C A 10: 9,642,931 (GRCm39) G1056V probably damaging Het
Stxbp5 A C 10: 9,642,923 (GRCm39) S1059A probably benign Het
Taldo1 T A 7: 140,978,496 (GRCm39) S149T possibly damaging Het
Tlr1 T C 5: 65,084,442 (GRCm39) D45G possibly damaging Het
Tnrc6a T C 7: 122,770,558 (GRCm39) S783P probably damaging Het
Trap1 A G 16: 3,878,673 (GRCm39) Y220H probably benign Het
Trpc6 A G 9: 8,643,601 (GRCm39) D462G possibly damaging Het
Ttc21a A G 9: 119,773,028 (GRCm39) E235G probably damaging Het
Tubb4a A G 17: 57,387,833 (GRCm39) Y398H probably damaging Het
Ube2z A G 11: 95,941,233 (GRCm39) F303S probably damaging Het
Vmn1r211 A G 13: 23,036,254 (GRCm39) S138P probably damaging Het
Zfp1002 T A 2: 150,097,198 (GRCm39) Y77F possibly damaging Het
Zfp93 T A 7: 23,975,054 (GRCm39) C346* probably null Het
Zfp938 A T 10: 82,063,400 (GRCm39) S52R possibly damaging Het
Zp1 A T 19: 10,893,867 (GRCm39) L446Q probably damaging Het
Other mutations in Braf
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00492:Braf APN 6 39,637,933 (GRCm39) splice site probably null
IGL01616:Braf APN 6 39,628,586 (GRCm39) missense probably damaging 1.00
IGL01621:Braf APN 6 39,623,787 (GRCm39) intron probably benign
IGL01825:Braf APN 6 39,616,524 (GRCm39) missense probably damaging 0.99
IGL02435:Braf APN 6 39,623,700 (GRCm39) missense probably benign 0.00
IGL02629:Braf APN 6 39,665,233 (GRCm39) missense possibly damaging 0.83
IGL02751:Braf APN 6 39,637,801 (GRCm39) splice site probably benign
IGL02829:Braf APN 6 39,604,662 (GRCm39) missense possibly damaging 0.62
R0041:Braf UTSW 6 39,617,413 (GRCm39) missense probably damaging 1.00
R0041:Braf UTSW 6 39,617,413 (GRCm39) missense probably damaging 1.00
R0497:Braf UTSW 6 39,617,483 (GRCm39) splice site probably benign
R0512:Braf UTSW 6 39,641,923 (GRCm39) splice site probably benign
R0604:Braf UTSW 6 39,600,631 (GRCm39) missense probably damaging 1.00
R0726:Braf UTSW 6 39,639,082 (GRCm39) missense possibly damaging 0.90
R1468:Braf UTSW 6 39,642,017 (GRCm39) missense probably damaging 1.00
R1468:Braf UTSW 6 39,642,017 (GRCm39) missense probably damaging 1.00
R1616:Braf UTSW 6 39,620,067 (GRCm39) missense probably benign 0.35
R2160:Braf UTSW 6 39,639,007 (GRCm39) missense probably damaging 1.00
R3722:Braf UTSW 6 39,600,610 (GRCm39) missense probably damaging 1.00
R4407:Braf UTSW 6 39,592,654 (GRCm39) missense probably damaging 1.00
R4540:Braf UTSW 6 39,621,267 (GRCm39) missense probably damaging 1.00
R5026:Braf UTSW 6 39,665,221 (GRCm39) missense probably benign 0.22
R5478:Braf UTSW 6 39,654,508 (GRCm39) missense possibly damaging 0.94
R6993:Braf UTSW 6 39,620,097 (GRCm39) missense probably damaging 1.00
R7251:Braf UTSW 6 39,654,504 (GRCm39) critical splice donor site probably null
R7385:Braf UTSW 6 39,642,042 (GRCm39) critical splice acceptor site probably null
R7483:Braf UTSW 6 39,604,772 (GRCm39) missense possibly damaging 0.86
R7511:Braf UTSW 6 39,665,187 (GRCm39) missense probably damaging 0.99
R7660:Braf UTSW 6 39,600,575 (GRCm39) missense possibly damaging 0.48
R8323:Braf UTSW 6 39,620,058 (GRCm39) missense possibly damaging 0.83
R8527:Braf UTSW 6 39,604,693 (GRCm39) missense probably benign 0.37
R8542:Braf UTSW 6 39,604,693 (GRCm39) missense probably benign 0.37
R8993:Braf UTSW 6 39,639,085 (GRCm39) missense probably damaging 0.99
R9573:Braf UTSW 6 39,600,544 (GRCm39) missense probably damaging 1.00
R9689:Braf UTSW 6 39,591,084 (GRCm39) missense probably damaging 0.99
Z1088:Braf UTSW 6 39,638,960 (GRCm39) missense probably damaging 1.00
Z1176:Braf UTSW 6 39,620,116 (GRCm39) missense probably damaging 1.00
Z1186:Braf UTSW 6 39,702,189 (GRCm39) missense unknown
Z1186:Braf UTSW 6 39,702,187 (GRCm39) missense unknown
Predicted Primers PCR Primer
(F):5'- GAGACATTCCTCTCAGTTTTGAC -3'
(R):5'- AATTGTCTAAAGCCCCGAGAAC -3'

Sequencing Primer
(F):5'- CAGATTGCAACAAGTGAATGAAAAC -3'
(R):5'- CCGAGAACACTGGCAGTTACTG -3'
Posted On 2018-03-15